Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
5.77
-0.46 (-7.38%)
At close: May 19, 2026, 4:00 PM EDT
5.68
-0.09 (-1.52%)
After-hours: May 19, 2026, 7:28 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $272.54 million as of May 19, 2026. Its market cap has increased by 46.85% in one year.
Market Cap
272.54M
Enterprise Value
202.60M
1-Year Change
46.85%
Ranking
Category
Stock Price
$5.77
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $272.54M, a decrease of -49.38%. That is a compound annual growth rate of -11.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 294.27M | 2.47% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| REGENXBIO | 292.61M |
| Abeona Therapeutics | 291.82M |
| NervGen Pharma | 288.11M |
| MacroGenics | 287.29M |
| Cellectis | 283.20M |
| AC Immune | 279.75M |
| Eledon Pharmaceuticals | 276.74M |
| Nuvectis Pharma | 273.21M |